142 related articles for article (PubMed ID: 31896551)
1. Maternal Type 1 Diabetes Reduces Autoantigen-Responsive CD4
Knoop J; Eugster A; Gavrisan A; Lickert R; Sedlmeier EM; Dietz S; Lindner A; Warncke K; Hummel N; Ziegler AG; Bonifacio E
Diabetes; 2020 Apr; 69(4):661-669. PubMed ID: 31896551
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
[TBL] [Abstract][Full Text] [Related]
3. Proinsulin-a pathogenic autoantigen in type 1 diabetes.
Narendran P; Mannering SI; Harrison LC
Autoimmun Rev; 2003 Jun; 2(4):204-10. PubMed ID: 12848947
[TBL] [Abstract][Full Text] [Related]
4. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
6. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
[TBL] [Abstract][Full Text] [Related]
7. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
8. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin.
Durinovic-Belló I; Wu RP; Gersuk VH; Sanda S; Shilling HG; Nepom GT
Genes Immun; 2010 Mar; 11(2):188-93. PubMed ID: 20054344
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.
Sarugeri E; Dozio N; Belloni C; Meschi F; Pastore MR; Bonifacio E
Clin Exp Immunol; 1998 Dec; 114(3):370-6. PubMed ID: 9844045
[TBL] [Abstract][Full Text] [Related]
10. Evidence for immunological priming and increased frequency of CD4+ CD25+ cord blood T cells in children born to mothers with type 1 diabetes.
Holm BC; Svensson J; Akesson C; Arvastsson J; Ljungberg J; Lynch K; Ivarsson SA; Lernmark A; Cilio CM;
Clin Exp Immunol; 2006 Dec; 146(3):493-502. PubMed ID: 17100770
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
14. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
15. Influence of maternal hyperglycaemia on cord blood mononuclear cells in response to diabetes-associated autoantigens.
Stechova K; Spalova I; Durilova M; Bartaskova D; Cerny M; Cerna M; Pithova P; Chudoba D; Stavikova V; Ulmannova T; Faresjö M
Scand J Immunol; 2009 Aug; 70(2):149-58. PubMed ID: 19630921
[TBL] [Abstract][Full Text] [Related]
16. Avidity-dependent programming of autoreactive T cells in T1D.
Durinovic-Belló I; Gersuk VH; Ni C; Wu R; Thorpe J; Jospe N; Sanda S; Greenbaum CJ; Nepom GT
PLoS One; 2014; 9(5):e98074. PubMed ID: 24844227
[TBL] [Abstract][Full Text] [Related]
17. Insulin's other life: an autoantigen in type 1 diabetes.
Mannering SI; Bhattacharjee P
Immunol Cell Biol; 2021 May; 99(5):448-460. PubMed ID: 33524197
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
[TBL] [Abstract][Full Text] [Related]
19. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
[TBL] [Abstract][Full Text] [Related]
20. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]